drug nanocrystals: novel technique for delivery of ... - Ijsidonline.info

More documents

Recommendations

Info

Sneha V Sawant et al., IJSID 2011, 1 (3), 1-1511. MüllerRH, GohlaS, Keck C, State of the art of nanocrystals – Special features, production, nanotoxicology aspects andintracellular delivery, European Journal of Pharmaceutics and Biopharmaceutics, 2011; 78(1): 1-9.12. Van Eerdenbrugh, B. et al, Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization andtransformation into solid products, Int. J. Pharm, 2008; 364: 64–75.13. Shegokar R, Müller RH, Nanocrystals: Industrially feasible multifunctional formulation technology for poorly solubleactives, International Journal of Pharmaceutics, 2010; 399(1-2): 129-139.14. Sharma S, Aggarwal G, Novel technologies for oral delivery of poorly soluble drugs, Research Journal of Pharmaceutical,Biological and Chemical Sciences,2010; 1(4):293-295.15. Katteboinaal S, Chandrasekhar P, Balaji S, Drug nanocrystals: a novel formulation approach for poorly soluble drugs,International Journal of PharmTech Research, 2009; 1(3): 682-694.16. Chen H, Khemtong C, Yang X, Chang X and Gao J, Nanonization strategies for poorly water soluble drugs, Drug DiscoveryToday, 2010;00:1-6.17. Bruno JAD, Brian D. Gustow Evan, Illig, Kathleen J, Rajagopalan, Nats, Sarpotdar, Method of grinding pharmaceuticalsubstances. US 5, 518,187, 1992.18. Miiller RH, Becker R, Kruss B and Peters K (1994) Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation alsSysteme mit erhohter Sattigungsloslichkeit und Losungsgeschwindigkeit. German patent 4440337.2, US Patent 5.858.410(1999).19. Rawat N, Kumar MS, Mahadeven N, Solubility: Particle Size Reduction is a Promising Approach to the Bioavailability ofLipophillic Drugs, International Journal of Recent Advances in Pharmaceutical Research, January 2011; 1: 8-18.20. Radke M, Pure drug nanoparticles for formulation of poorly soluble drug, New drug delivery: www.pharmasol-berlin.de.Kipp JE, Tak Wong JC, Doty MJ, Rebbeck CL. US Pat. application no. 20020168402 A1.200221. Türk M, Hils P, Helfgen B, Schaber K, Martin HJ, Wahl MA, Micronization of pharmaceutical substances by Rapid Expansionof Supercritical Solutions (RESS): a promising method to improve the bioavailability of poorly soluble pharmaceuticalagents, J Supercrit Fluids,2002:75–84.22. Pathak P, Meziani MJ, Desai T, Sun YP, Nanosizing drug particles in supercritical fluid processing , J Am Chem Soc,2004;126 (35): 10842–10843.23. Yin SX, Franchini M, Chen J, Hsieh A, JenS, Lee T, Hussain M, Smith R, Bioavailability Enhancement of a COX-2 Inhibitor,BMS-347070, from a Nanocrystalline Dispersion Prepared by Spray-Drying, J Pharm Sci.2005; 94: 1598–1607.24. Martin A, Bustamante P, ChunAHC, Interfacial phenomenon, Physical Pharmacy Lippincott Williams & Wilkins, Maryland,1993: 362–392.25. Merisko-Liversidge E, Liversidge GG, Cooper ER, Nanosizing: A Formulation Approach for Poorly-Water-SolubleCompounds, Eur J PharmSci.2003; 18: 113-120.26. Kesisoglou F, Panmai S, Wu Y, Nanosizing– Oral formulation development and biopharmaceutical evaluation, Adv DrugDelivRev,2007;59: 631–644.27. Gao L., Zhang D. et al, Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drugdelivery system, J Nanopart Res.2008; 10: 845-862.28. Müller RH, Jacobs C., et al., Nanosuspensions as particulate drug formulations in therapy rationale for development andwhat we can expect for the future, Adv. Drug Deliv. Rev, 2001; 47: 3-19.International Journal of Science Innovations and Discoveries, Volume 1, Issue 3, November-Deceber 201114
Sneha V Sawant et al., IJSID 2011, 1 (3), 1-1529. Liversidge GG, Cundy KC, Particle size reduction for improvement of oral bioavailability of hydrophobic drugs, Int J Pharm.1995; 125:91–97.30. Jacobs C, Kayser O, Müller RH, Production and characterisation of mucoadhesive nanosuspensions for the formulation ofbupravaquone, Int J Pharm, 2001; 214(1 –2):3–7.31. VergoteGJ, An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen, Int J Pharm,2001;219(1-2):81-7.32. Singla AK, Garg A, Aggarwal D, Paclitaxel and its formulations, Int J Pharm, 2002; 235(1–2):179–192.33. Müller RH and Jacobs C, Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability,Int. J. Pharm, 2002; 237: 151–161.34. Hernandez-Trejo N, Development and characterisation of buparvaquone nanosuspensions for pulmonary delivery in thetreatment of Pneumocystis pneumonia, Ph.D. Thesis, Freie Universität, Berlin, Germany, 2006.35. Hernandez-TrejoN, Kayser O, Steckel H and Müller RH, Characterization of nebulized buparvaquone nanosuspensionseffectof nebulization technology, J. Drug Target, 2005; 13: 499–507.36. Bucolo C, Maltese A, Puglisi G and Pignatello R, Enhanced ocular anti-inflammatory activity of ibuprofen carried by anEudragit RS100 nanoparticle suspension, Ophthalmic Res,2002; 34 : 319–323.37. Araújo J, Gonzalez E, Egea MA, Garcia ML and Souto EB, Nanomedicines for ocular NSAIDs: safety on drug delivery,Nanomed: Nanotechnol. Biol. Med, 2009; 5: 394–401.38. Kassem MA, Rahman A, Ghorab MM, Ahmed MB and Khalil RM, Nanosuspension as an ophthalmic delivery system forcertain glucocorticoid drugs, Int. J. Pharm, 2007;340: 126–133.39. Petersen R, Nanocrystals for use in topical cosmetic formulations and method of production thereof, US Patent60/8866233.40. Kayser O, Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against Leishmaniainfected macrophages, International Journal of Pharmaceutics, 2000;196(2):253-256.41. Raval J, Nanosuspensions as particulate drug delivery systems, 2006, Dec 27:http://www.pharmainfo.net/reviews/nanosuspensionsparticulate-drug-delivery-systems.42. Mauludin R, Nanosuspensions of poorly soluble drugs for oral administration, Ph.D. Thesis, Freie Universität Berlin,Germany,2008.43. Patel AP, PatelJK, Patel KS,A Review on drug nano crystals carrier free drug delivery system,IJRAP;2011,2(2),448-458.International Journal of Science Innovations and Discoveries, Volume 1, Issue 3, November-Deceber 201115
Page 1 and 2: Sneha V Sawant et al., IJSID 2011,
Page 13: Sneha V Sawant et al., IJSID 2011,

drug nanocrystals: novel technique for delivery of ... - Ijsidonline.info

Create successful ePaper yourself

Delete template?

Save as template?